Differential Evolution of Thyroid Peroxidase and Thyrotropin Receptor Antibodies in Graves' Disease: Thyroid Peroxidase Antibody Activity Reverts to Pretreatment Level After Carbimazole Withdrawal

Citations Over Time

Abstract

In this study, we compared the evolution of thyroid peroxidase antibody (TPOAb) and thyroid-stimulating antibody (TSAb) activities before, during, and after treatment of Graves' disease (GD) with carbimazole. TPOAb and TSAb were measured in sera from 75 patients with GD, during an 18-month block-replace regimen and after drug withdrawal (12, 24, and 36 months). At diagnosis, TPOAb were present in 85% of the patients versus 99% for TSAb. During the treatment, TPOAb values and prevalence significantly decreased, as observed with TSAb. After drug withdrawal, TPOAb levels increased once again to reach the pretreatment values, whereas TSAb remained unchanged. TPOAb values and prevalence at drug withdrawal were not significantly different between patients who remained euthyroid and those who had a relapse of hyperthyroidism. In contrast, TSAb values and prevalence were higher at drug withdrawal in relapse patients. In conclusion, TPOAb and TSAb changes are similar during GD treatment by carbimazole but diverge after drug withdrawal. TPOAb might reflect autoimmune perturbations independently of the clinical status and of the thyroid-stimulating activity.

Related Papers

• → Determination of the Level of IL-6 and Vaspin in Hyperthyroid Patients Treated with Carbimazole(2022)13 cited
• → Prediction of the Long-Term Results of Antithyroid Drug Therapy for Thyrotoxicosis(1970)87 cited
• → Effect of Iopanoic Acid on Radioiodine Therapy of Hyperthyroidism: Long-Term Outcome of a Randomized Controlled Trial(2005)14 cited
• → Red Cell Changes in Hyperthyroidism(1979)19 cited
• → RECOVERY OF INITIALLY SUPPRESSED THYROIDAL RADIOIODINE UPTAKE DURING LONG-TERM ANTITHYROID TREATMENT OF EUTHYROID VOLUNTEERS AND HYPERTHYROID PATIENTS(1972)7 cited